<DOC>
	<DOCNO>NCT01759732</DOCNO>
	<brief_summary>Rationale : Fludarabine , cyclophosphamide , anti-thymocyte globulin low-dose total body irradiation ( LD-TBI ) may induce engraftment cross immunologic barrier set HLA-haploidentical allogeneic hematopoietic cell transplantation . In addition , depletion CD3 cell may contribute prevent develop severe acute graft versus host disease ( GVHD ) haploidentical transplantation . Purpose : Phase II trial evaluate efficacy haploidentical stem cell transplantation fix dose T cell vitro T cell depletion use CD3 monoclonal antibody child acquire severe aplastic anemia</brief_summary>
	<brief_title>Haploidentical Stem Cell Transplantation Children With Acquired Severe Aplastic Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>Diagnosis lifethreatening marrow failure ( severe aplastic anemia ) nonmalignant etiology meet 2 follow criterion : Granulocyte count &lt; 500/mm3 , Corrected reticulocyte count &lt; 1 % , Platelet count &lt; 20,000/mm3 No HLAidentical family member closely match ( 8 8 HLAlocus match ) unrelated marrow donor available HLAhaploidentical relate donor available Paroxysmal nocturnal hemoglobinuria Fanconi anemia Clonal cytogenetic abnormality myelodysplastic syndrome Active fungal infection HIV positive Severe disease aplastic anemia would severely limit probability survival graft procedure Pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Aplastic anemia</keyword>
	<keyword>T cell dose</keyword>
	<keyword>CD3 depletion</keyword>
	<keyword>Haploidentical hematopoietic stem cell transplantation</keyword>
</DOC>